Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Dendritic Cell Vaccination in Glioblastoma Multiforme
NCT01006044Phase 2Completed
- Sponsor
- Universidad de Navarra
- Start
- Oct 2009
- Primary completion
- Aug 2014
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of autologous tumor lysate-pulsed dendritic cells in glioblastoma multiforme (GBM), sponsored by Universidad de Navarra. Started Oct 2009; status: completed.
02
Drugs
autologous tumor lysate-pulsed dendritic cells
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT01006044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01006044.